WisPaper
WisPaper
Search
Assistant
Pricing
TrueCite

Does previous dengue infection worsen subsequent infections?

Yes, prior dengue infection significantly raises the risk of severe dengue in a subsequent infection, especially after two years. Evidence from large studies and meta-analyses confirms this.

Direct answer

Yes, a previous dengue infection can make a subsequent infection much more dangerous. The largest study here, a population-based cohort in Taiwan, found that people with a second infection were about twice as likely to develop severe dengue (7.8% vs. 3.8%), and the risk more than tripled if the first infection was over two years ago [1]. A meta-analysis of placebo-controlled trials confirmed this, showing a nearly threefold higher odds of severe dengue after prior infection [2]. While a prior infection may lower your chance of getting a mild, lab-confirmed case again, it clearly raises the stakes if you do get sick, making severe outcomes like plasma leakage and shock more likely [2][5].

9sources cited

This article was generated with WisPaper-powered search and paper analysis.

Does a second dengue infection actually make you sicker?

Yes, and the evidence is consistent across multiple large studies. The most direct evidence comes from a 2024 population-based cohort study in Taiwan that followed over 3,900 people. It found that 7.8% of those with a secondary infection developed severe dengue, compared to 3.8% of those with a first infection—roughly doubling the odds (odds ratio 2.13) [1]. A 2024 meta-analysis of placebo groups from vaccine trials, which pooled data from thousands of participants, found an even stronger effect: prior infection was linked to nearly three times the odds of severe dengue (odds ratio 2.91) [2]. A 2015 systematic review that combined older prospective studies estimated the relative risk of dengue hemorrhagic fever or shock during a second infection at a striking 23.7 [9]. While the exact numbers vary, the direction is unmistakable: a second infection is substantially more dangerous.

This increased severity shows up in specific, measurable ways. A 2023 study in India of 220 dengue patients found that those with secondary infections were significantly more likely to have plasma leakage (seen as ascites and low blood protein), liver dysfunction, and dangerous drops in blood cell counts (pancytopenia) [3]. A 2022 study in Sri Lanka of 507 adults reported that prior dengue exposure—especially when combined with prior Zika exposure—raised the risk of plasma leakage, shock, and severe dengue [5]. These aren't abstract risks; they translate to real, life-threatening complications.

Does the time between infections matter?

Yes, the gap between your first and second dengue infection is critical. The Taiwan study found that the increased risk of severe dengue was only statistically significant when the interval between infections was more than two years (odds ratio 3.19) [1]. If the second infection occurred within two years, the risk was not significantly higher. This makes biological sense: the protective antibodies from the first infection wane over time, and at low levels they can paradoxically enhance the second infection rather than neutralize it—a phenomenon called antibody-dependent enhancement. A 2015 modeling study also highlighted that the duration of cross-protective immunity is a key factor driving this time-dependent risk [9].

This means that if you had dengue years ago, you are not 'immune' in a safe sense. You are actually in a higher-risk category for a severe outcome if you get infected again. Public health officials should be especially vigilant for people whose first infection was more than two years prior, as the Taiwan study authors recommend [1].

Are there any exceptions or other factors that change the risk?

While the overall pattern is clear, a few nuances are worth noting. First, prior infection actually reduces your chance of getting a lab-confirmed dengue infection at all—the meta-analysis found a 15% lower odds of virologically confirmed dengue after prior infection [2]. This suggests that prior immunity can prevent some infections entirely, but if it fails to prevent infection, the resulting illness tends to be more severe. Second, the risk is not uniform across all people. A 2007 study found that among those with secondary infections, people with blood type AB were significantly more likely to develop the most severe form of dengue hemorrhagic fever (grade 3) compared to other blood types [6]. Age also plays a role: a 2023 analysis of Mexican health data found that the effect of age on severity was partly mediated by whether it was a secondary infection, and that severe dengue clusters occurred in certain regions [7].

Interestingly, one 2023 study in Pakistan reported that while secondary infection was common (75% of dengue hemorrhagic fever patients), it did not reach statistical significance as a risk factor in their specific analysis [8]. This may reflect differences in study design or population, but it is a reminder that other factors like age, sex, and underlying health conditions (diabetes, hypertension) also contribute. Finally, a 2024 study found that recent dengue infection even modestly increased the risk and severity of a subsequent COVID-19 infection, suggesting that the immune disruption from dengue may have broader consequences [4].

About These Sources

This answer is built on 9 peer-reviewed studies — published from 2007 to 2024, 3 from 2024 or later, 3 in Q1 journals, collectively cited 88 times — selected as the most relevant from 11 studies that passed quality screening, drawn from 57 papers retrieved from a database of over 500 million.

Sources used in this answer

1

Risk of severe dengue during secondary infection: A population-based cohort study in Taiwan

In a population-based cohort study of 357 secondary and 3,570 primary dengue cases in Taiwan, secondary infection doubled the odds of severe dengue (OR 2.13), and the risk more than tripled (OR 3.19) when the interval between infections exceeded two years.

2

Impact of prior dengue infection on severity and outcomes: meta-analysis of placebo-controlled trials

A meta-analysis of placebo groups from three phase III vaccine trials found that prior dengue infection increased the odds of severe dengue nearly threefold (OR 2.91), but reduced the odds of any virologically confirmed dengue (OR 0.85).

3

Impact of secondary infections on dengue presentation: A cross-sectional study in a tertiary care hospital in Uttar Pradesh, India

In a cross-sectional study of 220 dengue patients in India, secondary infection was significantly associated with hemorrhagic manifestations, pancytopenia, plasma leakage (ascites, hypoproteinemia), and hepatic dysfunction.

4

Effects of Recent Prior Dengue Infection on Risk and Severity of Subsequent SARS-CoV-2 Infection: A Retrospective Cohort Study

A retrospective cohort study of over 3.3 million Singaporean adults found that recent prior dengue infection was associated with a modestly increased risk of subsequent SARS-CoV-2 infection (aHR 1.13) and significantly higher risks of COVID-19 hospitalization (aHR 3.25) and severe COVID-19 (aHR 3.39).

5

Effect of prior Zika and dengue virus exposure on the severity of a subsequent dengue infection in adults

In a prospective cohort of 507 adult dengue patients in Sri Lanka, prior dengue exposure (alone or combined with prior Zika exposure) was significantly associated with increased risks of plasma leakage, shock, and severe dengue.

6

Blood group AB is associated with increased risk for severe dengue disease in secondary infections.

Among 399 dengue patients in a cohort study, individuals with blood group AB who had secondary infections were significantly more likely to develop dengue hemorrhagic fever grade 3 than less severe forms (OR 0.097).

7

Direct and indirect effects of age on dengue severity: The mediating role of secondary infection

A mediation analysis of Mexican health data from 2012-2017 found that secondary infection mediated 17% of the effect of age on dengue severity, and severe dengue clusters were identified in northeastern and southeastern municipalities.

8

Risk Factors and Secondary Infections in Dengue Hemorrhagic Fever Patients

In a descriptive cross-sectional study of 256 dengue hemorrhagic fever patients in Pakistan, secondary infection was present in 75% of cases but was not a statistically significant risk factor in this analysis; males and those under 40 were more commonly affected.

9

On the risk of severe dengue during secondary infection: a systematic review coupled with mathematical modeling.

A systematic review and mathematical modeling study estimated the pooled relative risk of symptomatic illness during secondary infection at 9.4 and of dengue hemorrhagic fever/shock at 23.7, and identified the duration of cross-protective immunity as a key modulator of time-dependent risk.